Twice-Weekly Fasting Emerges as Leading Diet for Type 2 Diabetes Management in Thai Context
A new clinical trial identifies the 5:2 intermittent fasting plan as the most effective and sustainable option among three popular diets for improving blood sugar control in people with type 2 diabetes and obesity. Presented at ENDO 2025 in San Francisco, the findings carry meaningful implications for Thailand, where diabetes is rising and dietary trends are closely watched by clinicians and the public.
Thailand faces a growing diabetes burden, with more than seven million people living with the condition as of 2023, many of them overweight or obese. The Thai Ministry of Public Health has long emphasized dietary modification as central to diabetes care, yet selecting an accessible and effective plan remains challenging. A Thai-focused summary of the study highlights the potential value of structured intermittent fasting within a comprehensive management approach.
